| Financial Year |
March 31 2023 |
| Monetary Funds |
119,809,689.09 |
| Held-for-trading Financial Assets |
169,794,876.72 |
| Notes Receivable |
3,114,063.86 |
| Accounts Receivable |
274,523,494.17 |
| Advances to Suppliers |
18,108,264.07 |
| Other Receivables |
22,208,001.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
266,351,164.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
107,339,376.57 |
| Total Current Assets |
1,044,139,725.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,439,058.71 |
| Investment Properties |
52,693,168.20 |
| Fixed Assetes |
290,797,058.89 |
| Under-construction Projects |
9,143,280.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,094,993.81 |
| R&D expenses |
-- |
| Goodwill |
178,857,905.58 |
| Long-Term Deferred and Prepaid Expenses |
3,135,599.41 |
| Deferred Income Tax Assets |
16,288,903.86 |
| Other Non-Current Assets |
19,835,497.96 |
| Sub-Total of Non-Current Assets |
702,292,759.84 |
| Total Assets |
1,746,432,485.32 |
| Short-Term Loans |
23,252,460.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
109,870,813.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,897,719.14 |
| Taxes Payable |
18,022,555.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,571,385.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,231,263.35 |
| Other Current Liabilities |
3,950,405.80 |
| Sub-Total of Current Liabilities |
254,596,105.47 |
| Long-term Loans |
3,350,000.00 |
| Bonds Payable |
200,259,253.57 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,195,710.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
218,642,216.71 |
| Total Liabilities |
473,238,322.18 |
| Paid-In Capital(Or Share Stock) |
285,804,819.00 |
| Capital Surplus |
489,058,013.97 |
| Surplus Reserve |
40,727,389.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
329,126,769.00 |
| Minority Stockholder's Interest |
72,729,316.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,200,464,847.10 |
| Owner's Equity（Stockholder's Equity） |
1,273,194,163.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,746,432,485.32 |
